title: Does Levofloxacin Improve Parkinsonian Features or Is the Improvement Only Coincidental?
authors.affiliation: Department of Neurology, American University of Beirut Medical Center, Beirut, Lebanon rs01@aub.edu.lb.
authors.forename: Nabil
authors.initials: N
authors.lastname: El Ayoubi
authors.forename: Raja
authors.initials: R
authors.lastname: Sawaya
authors.forename: Raja
authors.initials: R
authors.lastname: Sawaya
mesh_terms: D000368:Aged; D065609:Cytochrome P-450 CYP1A2 Inhibitors / Q000627:therapeutic use*; D006801:Humans; D064704:Levofloxacin / Q000627:therapeutic use*; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D065609:Cytochrome P-450 CYP1A2 Inhibitors; D064704:Levofloxacin